Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5873285 | 0.94 | ALDH1A1 (0.52) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL10490440 | 0.84 | ALDH1A1 (0.47) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL8954554 | 0.84 | NPSR1 (0.47) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL8854160 | 0.83 | RAB9A (0.61) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL6131273 | 0.82 | TP53 (0.62) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL10396676 | 0.82 | L3MBTL1 (0.54) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL1624416 | 0.81 | ALOX5 (0.57) | ALDH1A1HTTKMT2ATDP1KEAP1 | |
| SCHEMBL27486724 | 0.79 | LTB4R2 (0.50) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL17202170 | 0.79 | ALDH1A1 (0.52) | ALDH1A1RAB9ANPSR1POLBNPC1 | |
| SCHEMBL7364286 | 0.79 | ALDH1A1 (0.50) | ALDH1A1RAB9ANPSR1POLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714985-A1 | DUAL CURE RESIN COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-20260049201-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2026-02-19 | — | — | US | disclosed |
| EP-4269462-B1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A THERMOPLASTIC POLYURETHANE | HENKEL AG & CO KGAA (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025119658-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | HENKEL AG & CO. KGAA (DE) | 2025-06-12 | — | — | WO | disclosed |
| WO-2025118203-A1 | BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE FILM ADHESIVE | HENKEL AG & CO. KGAA (DE) | 2025-06-12 | — | — | WO | disclosed |
| EP-4567085-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | Henkel AG & Co. KGaA (DE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4200344-B1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2025-05-07 | — | — | EP | disclosed |
| US-20250051612-A1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A BIO-RENEWABLE MONOMER | HENKEL AG & CO KGAA (DE) | 2025-02-13 | — | — | US | disclosed |
| US-20250043124-A1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A THERMOPLASTIC POLYURETHANE | HENKEL AG & CO. KGAA (DE) | 2025-02-06 | — | — | US | disclosed |
| CN-119095894-A | Two-component (2K) acrylic composition comprising thermoplastic polyurethane | 汉高股份有限及两合公司 | 2024-12-06 | — | — | CN | disclosed |
| US-20090281335-A1 | Cure Accelerators for Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
| WO-2009137448-A2 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009137444-A2 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009014688-A2 | NOVEL ADDUCTS USEFUL AS CURE COMPONENTS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20090025874-A1 | Novel Adducts Useful As Cure Components For Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-01-29 | — | — | US | disclosed |
| US-6835762-B1 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION | 2004-12-28 | — | — | US | disclosed |
| US-5041667-A | Process for producing chlorophenylhydrazine compounds | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1991-08-20 | — | — | US | disclosed |
| EP-0208477-B1 | PROCESS FOR PRODUCING CHLOROPHENYLHYDRAZINE COMPOUNDS | KONICA CORPORATION (JP) | 1989-03-15 | — | — | EP | disclosed |
| EP-0208477-A1 | Process for producing chlorophenylhydrazine compounds | KONICA CORPORATION (JP) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | ACLY, ACAD9, CCNY | ALDH1A1 262/4885RAB9A 3538/4885NPSR1 4777/4885 |
| US-20260049201-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | AHCY, AHCYL1, ALKBH3 | ALDH1A1 763/4885RAB9A 4475/4885NPSR1 3532/4885 |
| US-20090281335-A1 | Cure Accelerators for Anaerobic Curable Compositions | CAT, MRM1, ACLY | ALDH1A1 510/4885RAB9A 3697/4885NPSR1 4573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.